Article 24 Feb 2026 New FDA Drug Reforms: Congress Extends Voucher Incentive, Clarifies Orphan Exclusivity And Provides Greater Transparency For Q1/Q2 Generic Approvals United States Healthcare
Article 16 Feb 2026 FDA Tightens The Belt On GLP-1 Compounding, Escalating Threat Of Enforcement United States Healthcare
Article 13 Jan 2026 Turning Insight Into Action: A Life Sciences Playbook For 2026 United States Commercial
Article 12 Jan 2026 Ringing In The New Year With Digital Health: FDA Updates Guidance Documents On Clinical Decision Support Software And General Wellness Products United States Healthcare
Article 12 Dec 2025 National Advertising Division Puts Compounded GLP-1 Advertising On A Diet United States Media & IT
Article 05 Nov 2025 New FDA Guidance Could Speed Biosimilar Approvals And Cut Costs United States Healthcare